• Report SKU:SKU: HVR3385
  • Description
  • Table of Contents
  • Request Sample

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This research report analyzes the global markets with in-depth insights. The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K., Spain and ROE), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC), South America (Argentina, Brazil, Venezuela, Chile, and Peru) and Middle East & Africa (UAE, Saudi Arabia, Qatar, Iran, South Africa, and Rest of MEA). Annual estimations and forecasts are provided from the year 2016 to 2027 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides: ●  Market Sizing estimations and forecasts across the given market segments ●  Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, ) ●  Strategic recommendations in key business segments based on the market estimations ●  Regional and country level market analysis ●  Competitive landscaping of major market players ●  Company profiling covering the financials, recent activities and the future strategies

1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research Sources
1.4.2 Primary Research Sources
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Antivirals Market by Type
5.1 Introduction
5.2 Generic
5.3 Branded

6 Antivirals Market by Drug Class
6.1 Introduction
6.2 Neuraminidase Inhibitors
6.3 DNA Polymerase Inhibitors
6.4 Reverse Transcriptase Inhibitors
6.5 Protease Inhibitors
6.6 NS3 Protease inhibitors

7 Antivirals Market by Application
7.1 Introduction
7.2 Influenza
7.3 Hepatitis
7.4 Herpes
7.5 Human Immunodeficiency Virus (HIV)

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 South America
8.4.1 Argentina
8.4.2 Brazil
8.4.3 Venezuela
8.4.4 Chile
8.4.5 Peru
8.5 Middle East & Africa
8.5.1 UAE
8.5.2 Saudi Arabia
8.5.3 Qatar
8.5.4 Iran
8.5.5 South Africa
8.5.6 Rest of Middle East & Africa

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Roche
10.2 Novartis AG
10.3 Gilead Sciences Inc.
10.4 Merck
10.5 Johnson and Johnson
10.6 GlaxoSmithKline
10.7 Abbott Laboratories
10.8 AstraZeneca AB
10.9 BoehringerIngelheim Corporation
10.10 Schering-Plough
10.11 Dr Reddy’s
10.12 Cipla
10.13 Aurobindo Pharma
10.14 Bristol-Myers-Squibb
10.15 Mylan

11 Appendix

12 Disclaimer

List of Tables
Table 1 Global Antivirals Market Analysis, by Region, (2017-2027) ($MN)
Table 2 Global Antivirals Market Analysis, by Type, (2017-2027) ($MN)
Table 3 Global Antivirals Market Analysis, by Generic, (2017-2027) ($MN)
Table 4 Global Antivirals Market Analysis, by Branded, (2017-2027) ($MN)
Table 5 Global Antivirals Market Analysis, by Drug Class, (2017-2027) ($MN)
Table 6 Global Antivirals Market Analysis, by Neuraminidase Inhibitors, (2017-2027) ($MN)
Table 7 Global Antivirals Market Analysis, by DNA Polymerase Inhibitors, (2017-2027) ($MN)
Table 8 Global Antivirals Market Analysis, by Reverse Transcriptase Inhibitors, (2017-2027) ($MN)
Table 9 Global Antivirals Market Analysis, by Protease Inhibitors, (2017-2027) ($MN)
Table 10 Global Antivirals Market Analysis, by NS3 Protease inhibitors, (2017-2027) ($MN)
Table 11 Global Antivirals Market Analysis, by Application, (2017-2027) ($MN)
Table 12 Global Antivirals Market Analysis, by Influenza, (2017-2027) ($MN)
Table 13 Global Antivirals Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 14 Global Antivirals Market Analysis, by Herpes, (2017-2027) ($MN)
Table 15 Global Antivirals Market Analysis, by Human Immunodeficiency Virus (HIV) , (2017-2027) ($MN)
Table 16 North America Antivirals Market Analysis, by Country, (2017-2027) ($MN)
Table 17 North America Antivirals Market Analysis, by Type, (2017-2027) ($MN)
Table 18 North America Antivirals Market Analysis, by Generic, (2017-2027) ($MN)
Table 19 North America Antivirals Market Analysis, by Branded, (2017-2027) ($MN)
Table 20 North America Antivirals Market Analysis, by Drug Class, (2017-2027) ($MN)
Table 21 North America Antivirals Market Analysis, by Neuraminidase Inhibitors, (2017-2027) ($MN)
Table 22 North America Antivirals Market Analysis, by DNA Polymerase Inhibitors, (2017-2027) ($MN)
Table 23 North America Antivirals Market Analysis, by Reverse Transcriptase Inhibitors, (2017-2027) ($MN)
Table 24 North America Antivirals Market Analysis, by Protease Inhibitors, (2017-2027) ($MN)
Table 25 North America Antivirals Market Analysis, by NS3 Protease inhibitors, (2017-2027) ($MN)
Table 26 North America Antivirals Market Analysis, by Application, (2017-2027) ($MN)
Table 27 North America Antivirals Market Analysis, by Influenza, (2017-2027) ($MN)
Table 28 North America Antivirals Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 29 North America Antivirals Market Analysis, by Herpes, (2017-2027) ($MN)
Table 30 North America Antivirals Market Analysis, by Human Immunodeficiency Virus (HIV) , (2017-2027) ($MN)
Table 31 Europe Antivirals Market Analysis, by Country, (2017-2027) ($MN)
Table 32 Europe Antivirals Market Analysis, by Type, (2017-2027) ($MN)
Table 33 Europe Antivirals Market Analysis, by Generic, (2017-2027) ($MN)
Table 34 Europe Antivirals Market Analysis, by Branded, (2017-2027) ($MN)
Table 35 Europe Antivirals Market Analysis, by Drug Class, (2017-2027) ($MN)
Table 36 Europe Antivirals Market Analysis, by Neuraminidase Inhibitors, (2017-2027) ($MN)
Table 37 Europe Antivirals Market Analysis, by DNA Polymerase Inhibitors, (2017-2027) ($MN)
Table 38 Europe Antivirals Market Analysis, by Reverse Transcriptase Inhibitors, (2017-2027) ($MN)
Table 39 Europe Antivirals Market Analysis, by Protease Inhibitors, (2017-2027) ($MN)
Table 40 Europe Antivirals Market Analysis, by NS3 Protease inhibitors, (2017-2027) ($MN)
Table 41 Europe Antivirals Market Analysis, by Application, (2017-2027) ($MN)
Table 42 Europe Antivirals Market Analysis, by Influenza, (2017-2027) ($MN)
Table 43 Europe Antivirals Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 44 Europe Antivirals Market Analysis, by Herpes, (2017-2027) ($MN)
Table 45 Europe Antivirals Market Analysis, by Human Immunodeficiency Virus (HIV) , (2017-2027) ($MN)
Table 46 Asia Pacific Antivirals Market Analysis, by Country, (2017-2027) ($MN)
Table 47 Asia Pacific Antivirals Market Analysis, by Type, (2017-2027) ($MN)
Table 48 Asia Pacific Antivirals Market Analysis, by Generic, (2017-2027) ($MN)
Table 49 Asia Pacific Antivirals Market Analysis, by Branded, (2017-2027) ($MN)
Table 50 Asia Pacific Antivirals Market Analysis, by Drug Class, (2017-2027) ($MN)
Table 51 Asia Pacific Antivirals Market Analysis, by Neuraminidase Inhibitors, (2017-2027) ($MN)
Table 52 Asia Pacific Antivirals Market Analysis, by DNA Polymerase Inhibitors, (2017-2027) ($MN)
Table 53 Asia Pacific Antivirals Market Analysis, by Reverse Transcriptase Inhibitors, (2017-2027) ($MN)
Table 54 Asia Pacific Antivirals Market Analysis, by Protease Inhibitors, (2017-2027) ($MN)
Table 55 Asia Pacific Antivirals Market Analysis, by NS3 Protease inhibitors, (2017-2027) ($MN)
Table 56 Asia Pacific Antivirals Market Analysis, by Application, (2017-2027) ($MN)
Table 57 Asia Pacific Antivirals Market Analysis, by Influenza, (2017-2027) ($MN)
Table 58 Asia Pacific Antivirals Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 59 Asia Pacific Antivirals Market Analysis, by Herpes, (2017-2027) ($MN)
Table 60 Asia Pacific Antivirals Market Analysis, by Human Immunodeficiency Virus (HIV) , (2017-2027) ($MN)
Table 61 South America Antivirals Market Analysis, by Country, (2017-2027) ($MN)
Table 62 South America Antivirals Market Analysis, by Type, (2017-2027) ($MN)
Table 63 South America Antivirals Market Analysis, by Generic, (2017-2027) ($MN)
Table 64 South America Antivirals Market Analysis, by Branded, (2017-2027) ($MN)
Table 65 South America Antivirals Market Analysis, by Drug Class, (2017-2027) ($MN)
Table 66 South America Antivirals Market Analysis, by Neuraminidase Inhibitors, (2017-2027) ($MN)
Table 67 South America Antivirals Market Analysis, by DNA Polymerase Inhibitors, (2017-2027) ($MN)
Table 68 South America Antivirals Market Analysis, by Reverse Transcriptase Inhibitors, (2017-2027) ($MN)
Table 69 South America Antivirals Market Analysis, by Protease Inhibitors, (2017-2027) ($MN)
Table 70 South America Antivirals Market Analysis, by NS3 Protease inhibitors, (2017-2027) ($MN)
Table 71 South America Antivirals Market Analysis, by Application, (2017-2027) ($MN)
Table 72 South America Antivirals Market Analysis, by Influenza, (2017-2027) ($MN)
Table 73 South America Antivirals Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 74 South America Antivirals Market Analysis, by Herpes, (2017-2027) ($MN)
Table 75 South America Antivirals Market Analysis, by Human Immunodeficiency Virus (HIV) , (2017-2027) ($MN)
Table 76 Middle East & Africa Antivirals Market Analysis, by Country, (2017-2027) ($MN)
Table 77 Middle East & Africa Antivirals Market Analysis, by Type, (2017-2027) ($MN)
Table 78 Middle East & Africa Antivirals Market Analysis, by Generic, (2017-2027) ($MN)
Table 79 Middle East & Africa Antivirals Market Analysis, by Branded, (2017-2027) ($MN)
Table 80 Middle East & Africa Antivirals Market Analysis, by Drug Class, (2017-2027) ($MN)
Table 81 Middle East & Africa Antivirals Market Analysis, by Neuraminidase Inhibitors, (2017-2027) ($MN)
Table 82 Middle East & Africa Antivirals Market Analysis, by DNA Polymerase Inhibitors, (2017-2027) ($MN)
Table 83 Middle East & Africa Antivirals Market Analysis, by Reverse Transcriptase Inhibitors, (2017-2027) ($MN)
Table 84 Middle East & Africa Antivirals Market Analysis, by Protease Inhibitors, (2017-2027) ($MN)
Table 85 Middle East & Africa Antivirals Market Analysis, by NS3 Protease inhibitors, (2017-2027) ($MN)
Table 86 Middle East & Africa Antivirals Market Analysis, by Application, (2017-2027) ($MN)
Table 87 Middle East & Africa Antivirals Market Analysis, by Influenza, (2017-2027) ($MN)
Table 88 Middle East & Africa Antivirals Market Analysis, by Hepatitis, (2017-2027) ($MN)
Table 89 Middle East & Africa Antivirals Market Analysis, by Herpes, (2017-2027) ($MN)
Table 90 Middle East & Africa Antivirals Market Analysis, by Human Immunodeficiency Virus (HIV) , (2017-2027) ($MN)